Evidence map›Paper›PMID 36058852›Full record

ArticleJournal of cachexia, sarcopenia and muscle2022

Water T2 could predict functional decline in patients with dysferlinopathy.

Ursula Moore, Ericky Caldas de Almeida Araújo, Harmen Reyngoudt, Heather Gordish-Dressman, Fiona E Smith, Ian Wilson, Meredith James, Anna Mayhew, Laura Rufibach, John W Day and 17 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Compositional and Functional MRI of Skeletal Muscle: A Review.Journal of magnetic resonance imaging : JMRI · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Water T2 could predict functional decline in patients with dysferlinopathy.Journal of cachexia, sarcopenia and muscle · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 17 institutions in 8 countries.

Ursula MooreThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Ericky Caldas de Almeida AraújoNMR Laboratory, Neuromuscular Investigation Center, Institute of Myology, Paris, France.
Harmen ReyngoudtNMR Laboratory, Neuromuscular Investigation Center, Institute of Myology, Paris, France.
Heather Gordish-DressmanCenter for Translational Science, Division of Biostatistics and Study Methodology, Children's National Health System, Washington, DC, USA.
Fiona E SmithMagnetic Resonance Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Ian WilsonMagnetic Resonance Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Meredith JamesThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Anna MayhewThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Laura RufibachJain Foundation, Seattle, WA, USA.
John W DayDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Kristi J JonesThe Children's Hospital at Westmead and The University of Sydney, Sydney, NSW, Australia.
Diana X Bharucha-GoebelDepartment of Neurology, Children's National Health System, Washington, DC, USA.
Emmanuelle Salort-CampanaService des maladies neuromusculaire et de la SLA, Hôpital de La Timone, Marseille, France.
Alan PestronkDepartment of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
Maggie C WalterFriedrich-Baur-Institute, Department of Neurology, Ludwig-Maximilians-University of Munich, Munich, Germany.
Carmen ParadasNeuromuscular Unit, Department of Neurology, Hospital U. Virgen del Rocío/Instituto de Biomedicina de Sevilla, Sevilla, Spain.
Tanya StojkovicCentre de référence des maladies neuromusculaires, Institut de Myologie, AP-HP, Sorbonne Université, Hôpital Pitié-Salpêtrière, Paris, France.
Madoka Mori-YoshimuraDepartment of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.
Elena BravverNeuroscience Institute, Carolinas Neuromuscular/ALS-MDA Center, Carolinas HealthCare System, Charlotte, NC, USA.
Elena PegoraroDepartment of Neuroscience, University of Padova, Padua, Italy.
Jerry R MendellThe Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Jain COS Consortium
Kate BushbyThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Andrew M BlamireMagnetic Resonance Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Volker StraubThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Pierre G CarlierUniversité Paris-Saclay, CEA, DRF, Service Hospitalier Frederic Joliot, Orsay, France.
Jordi Diaz-ManeraThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.ORCID 0000-0003-2941-7988
Newcastle upon Tyne Hospitals NHS Foundation Trust · GBCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRNewcastle University · GBCarolinas Healthcare System · USChildren's National · USFriedrich Baur Stiftung · DEHôpital de la Timone · FRInstituto de Biomedicina de Sevilla · ESJain Foundation · USNational Center of Neurology and Psychiatry · JPNational Institutes of Health · USNationwide Children's Hospital · USSorbonne Université · FRStanford University · USThe University of Sydney · AUUniversity of Padua · ITWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWater T2 (T2

methodsPatients with genetically confirmed dysferlinopathy were assessed as part of the Jain Foundation Clinical Outcomes Study in dysferlinopathy. The cohort included 18 patients from two sites, both equipped with 3-tesla magnetic resonance imaging (MRI) systems from the same vendor. T2

resultsA higher T2

conclusionsIn dysferlinopathy, T2

Indexed as

Muscular DystrophiesMuscular Dystrophies, Limb-GirdleHumansMuscle, SkeletalWaterWaterLimb girdle muscular dystrophyLimb girdle muscular dystrophy 2BLimb girdle muscular dystrophy R2Magnetic resonance imagingWater T2

Identifiers

PMID36058852
PMCPMC9745487
OpenAlexW4294666593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.